Laxmiratna and Sapphisun Pharmaceuticals have Forged a joint venture with FUTURE PHARM in South Africa, with offices in Cape Town and Johannesburg.

The primary purpose of this joint venture is to engage in diverse business development like registration and distribution of own brand, vaccines, medical devices, etc., participation in various tenders and importation of pharmaceutical products under a special license, third party manufacturing, technology transfer in the Sub Sahara Africa and East African Countries.

The joint venture company has established a long-term business relationship with various multinational pharmaceutical companies across the globe from the USA, Europe, China, Canada, and Australia for sourcing and registration of products.